Evidence map›Paper›PMID 36678377›Full record

ReviewPathogens (Basel, Switzerland)2022

Many Ways to Communicate-Crosstalk between the HBV-Infected Cell and Its Environment.

Annika Jasmin Walter, Maarten A van de Klundert, Stephanie Jung

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Annika Jasmin WalterInstitute of Cardiovascular Immunology, University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.
Maarten A van de KlundertDivision of Infectious Diseases, Department of Medicine, Karolinska Institutet, 14152 Stockholm, Sweden.ORCID 0000-0001-6407-9481
Stephanie JungInstitute of Cardiovascular Immunology, University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.ORCID 0000-0002-1454-9358
University of Bonn · DEKarolinska Institutet · SE

Funding

Deutsche Forschungsgemeinschaft EXC2151-390873048German Center for Infection Research TTU 05.912
6 · The paper itself

Abstract

Chronic infection with the hepatitis B virus (HBV) affects an estimated 257 million people worldwide and can lead to liver diseases such as cirrhosis and liver cancer. Viral replication is generally considered not to be cytopathic, and although some HBV proteins may have direct carcinogenic effects, the majority of HBV infection-related disease is related to chronic inflammation resulting from disrupted antiviral responses and aberrant innate immune reactions. Like all cells, healthy and HBV-infected cells communicate with each other, as well as with other cell types, such as innate and adaptive immune cells. They do so by both interacting directly and by secreting factors into their environment. Such factors may be small molecules, such as metabolites, single viral proteins or host proteins, but can also be more complex, such as virions, protein complexes, and extracellular vesicles. The latter are small, membrane-enclosed vesicles that are exchanged between cells, and have recently gained a lot of attention for their potential to mediate complex communication and their potential for therapeutic repurposing. Here, we review how HBV infection affects the communication between HBV-infected cells and cells in their environment. We discuss the impact of these interactions on viral persistence in chronic infection, as well as their relation to HBV infection-related pathology.

Indexed as

cell-cell interactionsextracellular vesicleshepatitis B virushepatocellular carcinomainnate and adaptive immune responseviral spread

Identifiers

PMID36678377
PMCPMC9866324
OpenAlexW4313244933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.